Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
VISTA immune checkpoint blunts radiotherapy-induced antitumor immune response.
Journal: Cell reports
Published: November 13, 2024
An engineered ultrahigh affinity bi-paratopic uPAR targeting agent confers enhanced tumor targeting.
An engineered ultrahigh affinity bi-paratopic uPAR targeting agent confers enhanced tumor targeting.
Journal: Biotechnology and bioengineering
Published: May 03, 2024
Enhanced safety and efficacy of protease-regulated CAR-T cell receptors.
Journal: Cell
Published: January 13, 2021
An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA.
An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA.
Journal: Scientific reports
Published: May 23, 2020
An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy.
Journal: Communications biology
Published: May 15, 2020
Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation.
Journal: Cell reports
Published: April 12, 2019
Showing 1-7 of 7
Last Updated: 09/26/2026